TABLE 1.
Summary of results for 947 SLE patients and 1,113 controls tested for anti-Rib-P antibodies by means of the Rib-TriPlex assay
| Disease or disorder | No. of patients | No. of positive results with Rib-TriPlex assay | % Positive results | Mean (RU) | SD | Maximum |
|---|---|---|---|---|---|---|
| SLE | 947 | 201 | 21.3 | 1.3 | 4 | 46.2 |
| All controls | 1,113 | 8 | 0.7 | 0.45 | 0.46 | 9.7 |
| Infectious diseases | 140 | 1 | 0.7 | 0.33 | 0.28 | 2.5 |
| Cytomegalovirus | 20 | 0 | 0.0 | 0.29 | 0.12 | 0.6 |
| Epstein-Barr virus | 20 | 0 | 0.0 | 0.5 | 0.29 | 1.3 |
| Human immunodeficiency virus | 20 | 0 | 0.0 | 0.34 | 0.13 | 0.7 |
| Hepatitis C virus | 68 | 1 | 1.5 | 0.3 | 0.35 | 2.3 |
| Unidentified infectious disease | 12 | 0 | 0.0 | 0.37 | 0.19 | 0.4 |
| Rheumatic disorders | 544 | 7 | 1.3 | 0.46 | 0.56 | 9.7 |
| RA | 284 | 3 | 1.1 | 0.44 | 0.27 | 8.4 |
| Systemic sclerosis | 131 | 2 | 1.5 | 0.43 | 0.44 | 3.7 |
| Mixed connective tissue disease | 36 | 1 | 2.8 | 0.38 | 0.21 | 1.9 |
| PM | 15 | 1 | 6.7 | 0.95 | 2.33 | 9.7 |
| Sjögren's syndrome | 41 | 0 | 0.0 | 0.5 | 0.22 | 1.11 |
| PM/dermatomyositis | 37 | 0 | 0.0 | 0.4 | 0.18 | 0.9 |
| Vasculitis/thrombosis | 32 | 0 | 0 | 0.4 | 0.22 | 1.0 |
| Wegener’s grandonatosis | 6 | 0 | 0.0 | 0.15 | 0.08 | 0.3 |
| Antiphospholipid syndrome | 26 | 0 | 0.0 | 0.45 | 0.2 | 1.0 |
| Organ-specific disorders | 23 | 0 | 0 | 0.18 | 0.8 | 0.4 |
| Hashimoto thyroiditis | 11 | 0 | 0.0 | 0.17 | 0.09 | 0.4 |
| Graves' disease | 12 | 0 | 0.0 | 0.19 | 0.6 | 0.3 |
| Others | 374 | 0 | 0 | 0.33 | 0.16 | 1.1 |
| Familial Mediterranean fever | 20 | 0 | 0.0 | 0.28 | 0.7 | 0.4 |
| Normal human serum | 208 | 0 | 0.0 | 0.32 | 0.15 | 0.8 |
| Crohn's disease | 25 | 0 | 0.0 | 0.41 | 0.23 | 1.1 |
| Diverse diseases | 121 | 0 | 0.0 | 0.36 | 0.17 | 0.6 |